Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

physicians total care, inc. - levonorgestrel (unii: 5w7sia7yzw) (levonorgestrel - unii:5w7sia7yzw), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - levonorgestrel 0.15 mg - seasonique® (levonorgestrel/ethinyl estradiol tablets and ethinyl estradiol tablets) is indicated for use by women to prevent pregnancy. do not prescribe seasonique to women who are known to have the following: - a high risk of arterial or venous thrombotic diseases. examples include women who are known to: smoke, if over age 35 [see boxed warning and warnings and precautions (5.1)]. have deep vein thrombosis or pulmonary embolism, now or in the past [see warnings and precautions (5.1)] have cerebrovascular disease [see warnings and precautions (5.1)] have coronary artery disease [see warnings and precautions (5.1)] have thrombogenic valvular or thrombogenic rhythm diseases of the heart (for example, subacute bacterial endocarditis with valvular disease, or atrial fibrillation) [see warnings and precautions (5.1)] have inherited or acquired hypercoagulopathies [see warnings and precautions (5.1)] have uncontrolled hypertension [see warnings and precautions (5.4)] . have diabetes with vascular

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

astrazeneca pty ltd - acalabrutinib, quantity: 100 mg - capsule, hard - excipient ingredients: iron oxide yellow; indigo carmine aluminium lake; pregelatinised starch; sodium starch glycollate type a; gelatin; shellac; silicified microcrystalline cellulose; propylene glycol; titanium dioxide; iron oxide black; magnesium stearate - calquence is indicated for the treatment of patients with mantle cell lymphoma who have received at least one prior therapy. calquence is indicated for the treatment of patients with mantle cell lymphoma who have received at least one prior therapy.,calquence is indicated for the treatment of patients with chronic lymphocytic leukaemia(cll)/small lymphocytic lymphoma (sll).

Australien - Englisch - APVMA (Australian Pesticides and Veterinary Medicines Authority)

valent biosciences a div of sumitomo chemical australia - bacillus thuringiensis subsp. israelensis serotype h14 - aqueous suspension - bacillus thuringiensis subsp. israelensis serotype h14 biological-organism-bt-israele active 0.0 p - insecticide - ditch | flood water | irrigation water | sewage settling pond | stagnant pond | standing water | storm water | tidal water saltm - australian house mosquito | brown house mosquito | common australian mosquito | common banded mosquito | domestic container mosquito | saltmarsh culex | saltmarsh mosquito-ochlerotatus vigilax | aedes notoscriptus | aedes vigilax

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - nitrofurantoin, quantity: 100 mg - capsule, hard - excipient ingredients: magnesium stearate; purified talc; pregelatinised maize starch; lactose monohydrate; titanium dioxide; sunset yellow fcf; purified water; quinoline yellow; gelatin - treatment of urinary tract infections such as cystitis and pyelitis when due to susceptible pathogens. nitrofurantoin does not reach effective levels in plasma and consequently is not indicated for cortical or perinephric abscesses and in cases of prostatitis.

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - nitrofurantoin, quantity: 50 mg - capsule, hard - excipient ingredients: pregelatinised maize starch; magnesium stearate; purified talc; lactose monohydrate; titanium dioxide; sunset yellow fcf; purified water; quinoline yellow; gelatin - treatment of urinary tract infections such as cystitis and pyelitis when due to susceptible pathogens. nitrofurantoin does not reach effective levels in plasma and consequently is not indicated for cortical or perinephric abscesses and in cases of prostatitis.

Australien - Englisch - Department of Health (Therapeutic Goods Administration)

dr reddy's laboratories australia pty ltd - quetiapine fumarate -

Südafrika - Englisch - South African Health Products Regulatory Authority (SAHPRA)

astrazeneca pharmaceuticals (pty) ltd - capsules - see ingredients - each capsule contains acalabrutinib 100,0 mg

Vereinigte Staaten - Englisch - NLM (National Library of Medicine)

teva women's health llc - levonorgestrel (unii: 5w7sia7yzw) (levonorgestrel - unii:5w7sia7yzw), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - levonorgestrel 0.15 mg - seasonique® is indicated for use by females of reproductive potential to prevent pregnancy. seasonique is contraindicated in females who are known to have or develop the following conditions: - a high risk of arterial or venous thrombotic diseases. examples include females who are known to: smoke, if over age 35 [see boxed warning and warnings and precautions (5.1)]. have current or history of deep vein thrombosis or pulmonary embolism [see warnings and precautions (5.1)]. have cerebrovascular disease [see warnings and precautions (5.1)] have coronary artery disease [see warnings and precautions (5.1)]. have thrombogenic valvular or thrombogenic rhythm diseases of the heart (for example, subacute bacterial endocarditis with valvular disease, or atrial fibrillation) [see warnings and precautions (5.1)]. have inherited or acquired hypercoagulopathies [see warnings and precautions (5.1)]. have uncontrolled hypertension or hypertension with vascular disease [see warnings and precautions ( 5.3 )].

Israel - Englisch - Ministry of Health

abic marketing ltd, israel - lipegfilgrastim - solution for injection - lipegfilgrastim 6 mg / 0.6 ml - lipegfilgrastim - reduction in the duration of neutropenia and the incidence of febrile neutropenia in adult patients treated with cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes).

Irland - Englisch - HPRA (Health Products Regulatory Authority)

krka, d.d., novo mesto - quetiapine - prolonged-release tablet - 50 milligram(s) - diazepines, oxazepines, thiazepines and oxepines; quetiapine - diazepines, oxazepines, thiazepines and oxepines - quentiax sr is indicated for:
treatment of schizophrenia
treatment of bipolar disorder: for the treatment of moderate to severe manic episodes in bipolar disorder for the treatment of major depressive episodes in bipolar disorder for the prevention of recurrence of manic or depressed episodes in patients with bipolar disorder who previously responded to quetiapine treatment.
add-on treatment of major depressive episodes in patients with major depressive disorder (mdd) who have had sub-optimal response to antidepressant monotherapy (see section 5.1). prior to initiating treatment, clinicians should consider the safety profile of quentiax sr